Tracking stem cells in the cardiovascular system

Elie R Chemaly1, Ryuichi Yoneyama, John V Frangioni

  • 1Cardiology Laboratory of Integrative Physiology & Imaging, Cardiovascular Research Center, Massachusetts General Hospital, Boston, USA.

Insights

Tracking stem cells in vivo is crucial for cardiovascular therapeutics. This review explores imaging techniques and contrast agents for real-time monitoring of stem cell behavior in living subjects.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Biomedical Imaging

Background:

  • Stem cells show promise for treating cardiovascular diseases.
  • Current methods for tracking stem cells rely on ex vivo analysis of animal models.
  • There is a need for non-invasive in vivo methods to monitor stem cell fate.

Purpose of the Study:

  • To review current and emerging imaging techniques for in vivo stem cell tracking.
  • To discuss various contrast agents used for enhancing stem cell visibility in imaging.
  • To highlight the importance of in vivo tracking for advancing stem cell therapies.

Main Methods:

  • Literature review of published studies on stem cell tracking.
  • Analysis of different imaging modalities (e.g., MRI, PET, SPECT, Ultrasound).
  • Evaluation of contrast agents (e.g., superparamagnetic iron oxides, fluorescent dyes, radionuclides).

Main Results:

  • In vivo tracking allows real-time assessment of stem cell distribution, migration, and survival.
  • Various imaging techniques offer different spatial and temporal resolutions for stem cell monitoring.
  • Contrast agent selection impacts imaging sensitivity, safety, and long-term tracking capabilities.

Conclusions:

  • In vivo stem cell tracking is essential for optimizing cardiovascular therapeutic strategies.
  • Advanced imaging techniques and novel contrast agents are critical for successful stem cell therapy development.
  • Further research is needed to refine non-invasive tracking methods for clinical translation.